Bioage Labs Inc. sell geldnutzer
Start price
13.01.25
/
60%
€4.52
Target price
13.01.26
€3.00
Performance (%)
123.45%
End price
08.12.25
€10.10
Summary
This prediction ended on 08.12.25 with a price of €10.10. The SELL prediction by geldnutzer for Bioage Labs Inc. was trending in the completely wrong direction and closed with a performance of 123.45%. geldnutzer has a follow-up prediction for Bioage Labs Inc., but this time predicts that Bioage Labs Inc. is a Buy. geldnutzer has 60% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Bioage Labs Inc. | -1.786% | -1.786% |
| iShares Core DAX® | 0.869% | 3.389% |
| iShares Nasdaq 100 | -0.852% | -2.157% |
| iShares Nikkei 225® | 0.436% | 1.060% |
| iShares S&P 500 | -0.122% | -0.270% |
According to geldnutzer what are the pros and cons of Bioage Labs Inc. for the foreseeable future?
Pros
Could be worthwhile Investment >10% per year
Revenue growth >5% per year expected
EBIT growth >5% per year expected
Higher EBIT margin than peer group
Fair valuation
Good rating
Standard Investments for future growth
Valuable balance sheet
Capable Management
Some uniques
Differentiated customer and product portfolio
Stable Large shareholder and/or long term investor
Medium risks for its business
Top 10 in its market
Future proof or reliable business model
Cons
Low dividend yield expected
negative Cash Flow expected
ROE lower than 10% per year
Increased challenges to pay loans and raise capital
Little innovation
Growths slower than the competition
Sustainability is little important
Significant cyclical dependencies
Little known brand
Comments by geldnutzer for this prediction
In the thread Bioage Labs Inc. diskutieren
Sell mit Kursziel 4,0
Kursziel geändert auf 3,0